Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Genzyme to Resubmit LemtradaTM Application for FDA Review
Genzyme receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) application
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Age-dependent effects on the treatment response of natalizumab in MS patients.
CNS myelin wrapping is driven by actin disassembly.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Building a better sphingosine kinase-1 inhibitor.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
Physiotherapy as an immunoactive therapy? A pilot study.
Guillain-Barré syndrome in Colombia: where do we stand now?
Mobile phones and multiple sclerosis - a nationwide cohort study in denmark.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.

Pages